BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mayer O, Bruthans J, Seidlerová J, Karnosová P, Mateřánková M, Gelžinský J, Rychecká M, Opatrný J, Wohlfahrt P, Kučera R, Trefil L, Cífková R, Filipovský J, Vermeer C. The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients. Nutrition, Metabolism and Cardiovascular Diseases 2021;31:540-51. [DOI: 10.1016/j.numecd.2020.09.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lees JS, Mark PB, Witham MD. Vitamin K and vascular calcification. Curr Opin Nephrol Hypertens 2021;30:430-6. [PMID: 33871429 DOI: 10.1097/MNH.0000000000000712] [Reference Citation Analysis]
2 Hariri E, Kassis N, Iskandar JP, Schurgers LJ, Saad A, Abdelfattah O, Bansal A, Isogai T, Harb SC, Kapadia S. Vitamin K2-a neglected player in cardiovascular health: a narrative review. Open Heart 2021;8:e001715. [PMID: 34785587 DOI: 10.1136/openhrt-2021-001715] [Reference Citation Analysis]
3 Lees JS, Rankin AJ, Gillis KA, Zhu LY, Mangion K, Rutherford E, Roditi GH, Witham MD, Chantler D, Panarelli M, Jardine AG, Mark PB. The ViKTORIES trial: A randomized, double‐blind, placebo‐controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients. Am J Transplant 2021;21:3356-68. [DOI: 10.1111/ajt.16566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mayer O, Bruthans J, Seidlerová J, Gelžinský J, Kučera R, Karnosová P, Mateřánková M, Rychecká M, Wohlfahrt P, Cífková R, Filipovský J, Vermeer C. Low vitamin K status, high sclerostin and mortality risk of stable coronary heart disease patients. Biomark Med 2021;15:1465-77. [PMID: 34668399 DOI: 10.2217/bmm-2021-0168] [Reference Citation Analysis]